You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Osteoporosis

Denosumab for the prevention of osteoporotic fractures in postmenopausal women

  • Technology appraisal guidance
  • Reference number: TA204
  • Published:  27 October 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Appraisal Committee members and NICE project team
  • 7 Sources of evidence considered by the Committee
  • Update information

Update information

February 2014: Implementation section updated to clarify that denosumab is recommended as an option for preventing osteoporotic fractures in postmenopausal women. Additional minor maintenance update also carried out.

ISBN: 978-1-4731-6367-6


Previous page 7 Sources of evidence considered by the Committee
Back to top